These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1747577)

  • 1. beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
    Solomon SA; Ramsay LE; Yeo WW; Parnell L; Morris-Jones W
    BMJ; 1991 Nov; 303(6810):1100-4. PubMed ID: 1747577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
    Roberts DH; Tsao Y; McLoughlin GA; Breckenridge A
    Lancet; 1987 Sep; 2(8560):650-3. PubMed ID: 2887941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers for peripheral arterial disease.
    Paravastu SC; Mendonca DA; Da Silva A
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD005508. PubMed ID: 24027118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
    Meyer TE; Adnams C; Commerford P
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):909-13. PubMed ID: 8011570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
    Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension.
    Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID
    Drugs; 1988; 35 Suppl 4():29-35. PubMed ID: 3288468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension.
    Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID
    Eur J Clin Pharmacol; 1988; 34(6):543-8. PubMed ID: 3049118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aims of combination therapy--improved quality of life or better blood pressure control?
    Maclean D
    Drugs; 1988; 35 Suppl 4():16-21. PubMed ID: 3378514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.
    Maclean D; Mitchell ET; Coulson RR; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1988 Apr; 25(4):425-31. PubMed ID: 3289598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
    Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta blockers for peripheral arterial disease.
    Paravastu SC; Mendonca D; Da Silva A
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005508. PubMed ID: 18843692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina.
    Lai C; Onnis E; Pirisi R; Orani E; Delogu G; Cherchi A
    Drugs Exp Clin Res; 1988; 14(11):699-705. PubMed ID: 3073077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
    Sandberg M; Foale RA
    Drugs; 1988; 35 Suppl 4():51-5. PubMed ID: 3132360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
    Lepäntalo M
    Clin Pharmacol Ther; 1985 Jan; 37(1):7-12. PubMed ID: 3880687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.